Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program

Conditions: Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma

Sex: All

Ages: 50 Years – N/A

Healthy volunteers: Yes

Phase: NA

Enrollment: 201

Sponsor: Case Comprehensive Cancer Center

Location: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland Ohio

Summary

This project will pilot the expansion of the existing Taussig Outreach Program's community outreach and patient navigation model to study the multiple myeloma (MM) screening program. This involves analyzing community reception, screening program methods, reasons patients decided to participate, reasons patients declined participation, and participant views and attitudes. This study also aims to gauge the current and general understanding of MM. This study seeks to recruit participants in the pilot screening program to promote early detection. Participants who have abnormal results will receive patient navigation for further diagnostics and testing.

Eligibility Criteria

Inclusion Criteria: * Participant self-identifying as, or perceived as, Black and/or African-American * 50 years of age or older Exclusion Criteria: * Participants who do not self-identify as Black and/or African American * Under the age of 50 years

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05831358). StuddyBuddy aggregates publicly available trial information.